Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2236 to 2250 of 9128 results

  1. Aggressive behaviour in people receiving NHS or social care: prevention and management

    In development Reference number: GID-NG10432 Expected publication date:  28 January 2027

    NICE guideline
    In development

  2. Suspected sepsis: recognition, diagnosis and early management - procalcitonin testing

    In development Reference number: GID-NG10467 Expected publication date:  11 September 2026

    NICE guideline
    In development

  3. Software with artificial intelligence (AI)-derived algorithms to help interpret electroencephalograms (EEGs) for suspected epilepsy: early-use assessment

    In development Reference number: GID-HTG10865 Expected publication date:  15 September 2026

    HealthTech guidance
    In development

  4. Artificial intelligence (AI) technologies to assist histopathology for breast cancer diagnosis [ID6732]

    In development Reference number: GID-TA11959 Expected publication date:  17 June 2027

    Technology appraisal guidance
    In development

  5. Pembrolizumab with chemotherapy for adjuvant treatment of newly diagnosed high-risk endometrial cancer after surgery with curative intent [ID6207]

    In development Reference number: GID-TA11235 Expected publication date: TBC

    Technology appraisal guidance
    In development

  6. In-situ abdominal normothermic regional perfusion to preserve donor livers during retrieval for transplantation after controlled circulatory death

    In development Reference number: GID-HTG10880 Expected publication date:  19 November 2026

    HealthTech guidance
    In development

  7. Asciminib for untreated Philadelphia-chromosome-positive chronic myeloid leukaemia in the chronic phase

    Awaiting development Reference number: GID-TA12455 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  8. Xanomeline tartrate–trospium chloride for treating psychosis associated with Alzheimer's disease

    Awaiting development Reference number: GID-TA12460 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  9. Zilovertamab vedotin in combination for treating relapsed or refractory diffuse large B-cell lymphoma

    Awaiting development Reference number: GID-TA12458 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  10. Niraparib for treating newly diagnosed unmethylated glioblastoma

    Awaiting development Reference number: GID-TA12449 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  11. Trastuzumab deruxtecan for treating HER2-positive advanced gastric or gastro-oesophageal junction adenocarcinoma after trastuzumab-based treatment (review of TA879) [ID6680]

    In development Reference number: GID-TA11963 Expected publication date:  13 January 2027

    Technology appraisal guidance
    In development

  12. GNT0006 ATA-100 for treating FKRP-related limb girdle muscular dystrophy R9 [TSID12384]

    Awaiting development Reference number: GID-TA12009 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  13. VX-522 for treating cystic fibrosis unresponsive to CFTR modulators when there are 2 mutations in the CFTR gene [TSID12431]

    Awaiting development Reference number: GID-TA12478 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Depemokimab for treating eosinophilic granulomatosis with polyangiitis [TSID12383]

    Awaiting development Reference number: GID-TA12007 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Teplizumab for delaying progression of stage 3 type 1 diabetes in people 8 years and over [TSID12403]

    Awaiting development Reference number: GID-TA12037 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development